About 10 results found for searched term "84-26-4" (0.057 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M3668 | GDC-0994 | ERK |
| Ravoxertinib | ||
| Ravoxertinib (GDC-0994) is an orally active ERK kinase inhibitor with IC50 of 6.1 nM and 3.1 nM against ERK1 and ERK2, respectively. | ||
| M4437 | Rutaecarpine | COX |
| Rutecarpine | ||
| Rutaecarpine is a delayed rectifier K+ channel blocker, inhibits platelet aggregation. | ||
| M8722 | SYP-5 | Others |
| SYP-5 is potent and selective inhibitor of HIF-1 activity that decreases HIF-1α and HIF-1β protein levels under hypoxic condition. | ||
| M11250 | Zapnometinib | MEK |
| PD0184264; ATR-002 | ||
| Zapnometinib (PD0184264), an active metabolite of CI-1040, is an MEK inhibitor with an IC50 value of 5.7 nM. Zapnometinib has antiviral and antibacterial activity against influenza viruses. | ||
| M24639 | Aducanumab | Amyloid |
| BIIB037 | ||
| Aducanumab (BIIB037), a human monoclonal antibody selective for aggregated forms of amyloid beta (Aβ). Aducanumab shows brain penetration, and can be used for Alzheimer's disease (AD) research. | ||
| M25255 | Atacicept | Others |
| TACI-Ig; TACI-Fc 5 | ||
| Atacicept (TACI-Ig) is a is a recombinant fusion protein containing the extracellular, ligand-binding portion of the TACI receptor and the Fc portion of human IgG. Atacicept inhibits B cell stimulation by binding to B lymphocyte stimulator and a proliferation-inducing ligand. Atacicept can be used in research of B-cell autoimmune disease. | ||
| M29599 | Imlunestrant | Estrogen Receptor |
| LY-3484356 | ||
| Imlunestrant (LY-3484356) is an orally active, potent and selective estrogen receptor degrader (SERD) with pure antagonistic properties. Imlunestrant results in sustained inhibition of ER-dependent gene transcription and cell growth. Imlunestrant can be used for the research of ER-positive (ER+) advanced breast cancer (aBC) and endometrial endometrioid cancer (EEC). | ||
| M43319 | KLA peptide | Others |
| KLA peptide is a biological active peptide. | ||
| M50415 | human GIP(3-30), amide | Insulin Receptor |
| human GIP(3-30), amide is a high affinity antagonist of the human GIP receptor in vitro. | ||
| M54633 | FDW028 | Autophagy |
| FDW-028 | ||
| FDW028 is a potent and highly selective FUT8 inhibitor. FDW028 exhibits potent anti-tumor activity by defucosylation and impelling lysosomal degradation of B7-H3 through the CMA pathway. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
